Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 21,102 | 5,493 | 14,182 | 28,866 | 1,262 |
| Cost of Goods | 108 | 201 | 10 | 33 | 30 |
| Gross Profit | 20,994 | 5,292 | 14,172 | 28,833 | 1,232 |
| Operating Expenses | 22,098 | 20,274 | 26,369 | 25,130 | 26,941 |
| Operating Income | -996 | -14,781 | -12,187 | 3,736 | -25,679 |
| Interest Expense | 1,590 | 2,031 | 2,155 | 2,318 | 1,835 |
| Other Income | 1,543 | 1,283 | 1,573 | 1,834 | 2,219 |
| Pre-tax Income | -1,043 | -15,529 | -12,769 | 3,252 | -25,295 |
| Net Income Continuous | -1,043 | -15,529 | -12,769 | 3,252 | -25,295 |
| Net Income | $-1,043 | $-15,529 | $-12,769 | $3,252 | $-25,295 |
| EPS Basic Total Ops | 0.00 | -0.04 | -0.04 | 0.01 | -0.07 |
| EPS Basic Continuous Ops | 0.00 | -0.04 | -0.04 | 0.01 | -0.07 |
| EPS Diluted Total Ops | 0.00 | -0.04 | -0.04 | 0.01 | -0.07 |
| EPS Diluted Continuous Ops | 0.00 | -0.04 | -0.04 | 0.01 | -0.07 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.04 | -0.04 | 0.01 | -0.07 |
| EBITDA(a) | $-205 | $-14,168 | $-11,634 | $4,314 | $-25,102 |